Published in Clin Rheumatol on March 29, 2011
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology (2014) 1.25
Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential. Ther Adv Musculoskelet Dis (2013) 1.05
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford) (2014) 0.98
IL-17 in the rheumatologist's line of sight. Biomed Res Int (2013) 0.95
Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways. Immunology (2012) 0.93
IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators Inflamm (2012) 0.93
Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory th17 cells and therapeutic implications. Mediators Inflamm (2015) 0.92
Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis. Clin Exp Immunol (2014) 0.89
Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis. J Clin Immunol (2013) 0.89
Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis. Clin Exp Immunol (2013) 0.88
Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis. J Res Med Sci (2014) 0.87
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases. Arch Immunol Ther Exp (Warsz) (2015) 0.82
Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis. Clin Exp Immunol (2014) 0.81
Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine (2015) 0.81
Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol (2017) 0.80
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy. Vaccines (Basel) (2013) 0.78
Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation. Inflammation (2015) 0.78
Optimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts. Mediators Inflamm (2014) 0.78
The degree of CD4+ T cell autoreactivity determines cellular pathways underlying inflammatory arthritis. J Immunol (2014) 0.77
Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. Arthritis Res Ther (2016) 0.77
Modulating effects of leflunomide on the balance of Th17/Treg cells in collageninduced arthritis DBA/1 mice. Cent Eur J Immunol (2014) 0.77
The role of IL-17 in vitiligo: A review. Autoimmun Rev (2016) 0.76
Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis. Open Med (Wars) (2014) 0.75
Comment on "Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA". Clin Rheumatol (2011) 0.75
IL-17: a potential therapeutic target for rheumatoid arthritis? Clin Rheumatol (2012) 0.75
Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response. PLoS Negl Trop Dis (2015) 0.75
Human interleukin-27: wide individual variation in plasma levels and complex inter-relationships with interleukin-17A. Clin Exp Immunol (2014) 0.75
Gene Expression Profiling of IL-17A-Treated Synovial Fibroblasts from the Human Temporomandibular Joint. Mediators Inflamm (2015) 0.75
Expanded role for interleukin-17 in rheumatoid arthritis. Clin Rheumatol (2011) 0.75
Immunoselected STRO-3(+) mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis. Stem Cell Res Ther (2017) 0.75
Interluekin-17A (IL17A). Gene (2017) 0.75
The role of stromal cells in inflammatory bone loss. Clin Exp Immunol (2017) 0.75
Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity. PLoS One (2016) 0.75
The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation. Oncotarget (2016) 0.75
[Effector T cells]. Z Rheumatol (2015) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol (2007) 14.99
Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol (2007) 8.47
The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum (1992) 4.89
Rheumatoid arthritis. Lancet (2009) 4.69
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol (2000) 4.58
CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 3.74
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther (2005) 3.17
The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther (2004) 2.54
Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis (2007) 2.33
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods (2005) 2.09
Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum (2000) 1.96
TH-17 cells in rheumatoid arthritis. Arthritis Res Ther (2008) 1.93
Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol (2007) 1.43
Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells (2005) 1.41
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis (2009) 1.39
A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol (2004) 1.33
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J (2003) 1.20
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Curr Opin Pharmacol (2007) 1.17
Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther (2004) 1.11
Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol (2007) 0.94
A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev (2008) 0.78
Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression. Asian Pac J Cancer Prev (2015) 0.75